A baboon (Papio hamadryas) model of insulin-dependent diabetes
- 1 January 1995
- journal article
- research article
- Published by Wiley in Journal of Medical Primatology
- Vol. 24 (1) , 29-34
- https://doi.org/10.1111/j.1600-0684.1995.tb00141.x
Abstract
Over a period of four years, streptozocin has been used to induce diabetes in 10 baboons, all of whom are insulin dependent. We describe our experience with their husbandry, induction of diabetes, insulin therapy, metabolic control and growth rate. Streptozocin dosage of 60 mg/kg readily induces hyperglycemia with minimal hepatic or renal toxicity. Using a once daily injection of mixed short and intermediate acting insulins at a dosage of 2-4 U/kg, it is possible to maintain a degree of metabolic control similar to that attained in patients.Keywords
This publication has 9 references indexed in Scilit:
- Effect of nicotinic acid-induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons.Journal of Clinical Investigation, 1991
- Defects inβ-Cell Function and Insulin Sensitivity in Normoglycemic Streptozocin-Treated Baboons: A Model of Preclinical Insulin-Dependent Diabetes*Journal of Clinical Endocrinology & Metabolism, 1988
- Quantitative glomerular morphology of the normal and diabetic baboon kidneyDiabetologia, 1986
- Development of early lesions of microangiopathy in chronically diabetic monkeysDiabetes, 1984
- Nonhuman Primates as Models for the Study of Human Diabetes MellitusDiabetes, 1982
- A Comparison of Hemoglobin A1c in Human and Baboon BloodActa Haematologica, 1979
- Hemoglobin AIc in the Glucose-intolerant, Streptozotocin-treated or Pancreatectomized Macaque MonkeyDiabetes, 1978
- Spontaneous Diabetes in Macaca NigraDiabetes, 1972
- Diabetogenic Effects of Streptozotocin in Rhesus MonkeysDiabetes, 1970